The Company
Surgix develops the world’s first computer assisted surgery (C.A.S) solution, suitable for the time and accuracy sensitive environment of orthopedic trauma surgery, “surgery GPS”; Potential benefits, compared to conventional surgery, are dramatic: Improving accuracy and reducing very common complications, saving time and improving the OR economics, and enhancing surgeon safety by reducing X-Ray radiation exposure.
Surgix brings a compelling value proposition to the various levels of hospitals – clinical benefits to the surgeons, coupled by economic advantages to the hospital administration, and an ‘easy to digest’ business model for hospitals, industry and distribution partners.
Market Potential
Surgix suits an increasingly broad range of orthopedic surgery indications including high volume procedures such as hip fractures, long bone fractures, knee reconstruction surgery, and spine fixation (estimated 4.8 Million procedures/year, worldwide). Total addressable market is estimated at $1.8-2.5 Billion/year.
Unique Value Proposition
Benefits to Orthopedic surgeons and hospitals using Surgix:
- Improved accuracy of surgery
- Patient safety – reduction in common complications, and 80% reduction in trial-and-error
- Reduced X-Ray radiation exposure of OR staff
- Improved surgery economics – reduced surgery time, reduced waste of implants
Using a new technological approach than all traditional solutions, Surgix provide unique advantages:
- The only CAS solution in Orthopedics that does not change workflow
- The only CAS solution in Orthopedics that shorten surgery time (traditional solutions add between 30 minutes and an hour)
- The only CAS solution in Orthopedics that requires no learning curve (20 minutes training, vs. 2 weeks)
- The only CAS solution in Orthopedics that fits every surgeon in every relevant case.
Entrepreneur of the Year 2006
Surgix' founders have won Earnest & Young’s Entrepreneur of the Year contest for 2006, in the start-up (early stage) category.
The Team
Oren Drori - Co-founder & CEO:
Drori brings 8 years of leadership experience. Before founding Surgix, Drori served as head of marketing & top management member at the security vendor Commtouch (NASDAQ: CTCH). Prior to that Drori served as director of strategic marketing at Comverse (NASDAQ: CMVT) where he led the go-to-market of the company's next-generating product line. Drori holds an Economics and Business-Management BA (Dean's list) and Economics MA (Summa Cum Laude), both from Tel Aviv University. Drori was listed by Globes magazine among Israel's 40 most promising young executives, 2006.
Ram Nathaniel - Co-founder & CTO:
Nathaniel is a high caliber mathematician and algorithms expert. He brings 12 years of experience in algorithm development and strong army background (8200). Prior to founding Diagnostica Nathaniel headed the algorithms team in IO-Image, providing video-based products for homeland security. Fields of expertise include Machine-Learning, Natural Language, Image and Video Processing. Nathaniel holds BA in Mathematics (Dean’s list), and MA in applied math & computer-science (Suma Cum Laude), both from Tel Aviv University.
Professor Shmuel Dekel, MD, PhD - Co-founder:
Dekel serves as chief of orthopedic surgery department at Sorasky Medical Center in Tel Aviv and holds an associate clinical professor of orthopedic surgery position in Tel Aviv University. Dekel is an active world known researcher with over 100 publications. He was listed by among Israel's top 5 orthopedic surgeons (Maariv, 2006) and holds a PhD in Molecular Biology (Oxford).
Ido Kilemnik - VP Surgical Devices:
During his 12 years engineering career, Ido has founded 3 companies, issued over 30 patents and served as engineering executive (VP R&D, Chief Engineer or similar roles) in a number of companies including among other: Disc-o-tech, ByPass, Ventor, and Meditate.
Advisory Board
Eliezer Tokman: Tokman, currently CEO of Siemens Israel is a distinguished veteran executive of the medical imaging industry which, in a 30 years career has served in top management roles of medium-size to multi-billion corporations including Philips Medical Systems (as Senior Vice President, Business Integration), Marconi Medical Systems (as Senior Vice President for Product Strategies) and Elscint (various positions, including President of Elscint America, General Manager of the CT division).
Mark E. Schweitzer, MD: Chairman of Radiology - University of Ottawa, and Chief of Diagnostic Imaging - The Ottawa Hospital; world known researcher with over 500 publications attributed to him, serves in editorial board and as a manuscript reviewer in 17 academic journals.
Kenneth A. Egol, MD: Associate Professor Department of Orthopaedic Surgery at NYU School of Medicine; Chief of Orthopaedic Trauma Surgery and Vice Chair of Education for the residency program at NYU Hospital for Joint Diseases;
Roy I. Davidovitch, MD: Assistant Professor, Department of Orthopaedic Surgery at NYU School of Medicine; Director of the New York Hip Center, Hospital for Joint Diseases.
Status
Surgix is clinical (human) trials in selected clinical sites in Israel and abroad.
Contact